Trials / Terminated
TerminatedNCT00427960
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg
A Phase IV, 6-week, Randomised, Double-blind, Multicentre, Parallel Group, Comparative Study to Evaluate the Efficacy of Rosuvastatin 5mg and Atorvastatin 10mg in UK Asian Subjects With Primary Hypercholesterolaemia
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effectiveness and safety of rosuvastatin 5mg in lowering blood cholesterol, compared to one other medicine, atorvastatin 10mg in Asian patients in the UK.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Dietary advice | |
| DRUG | rosuvastatin | rosuvastatin 5 mg |
| DRUG | atorvastatin | atorvastatin 10 mg |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2007-01-29
- Last updated
- 2010-12-16
- Results posted
- 2010-03-22
Locations
9 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00427960. Inclusion in this directory is not an endorsement.